vitro natur killer lymphokine-activ killer activ patient bronchogen carcinoma author peripher blood mononuclear cell patient bronchogen carcinoma natur killer NK lymphokine-activ killer lak activ vitro incub media media interferon gamma ifn u/ml u/ml result lymphocyt patient bronchogen carcinoma lak activ level activ lymphocyt control subject cultur autolog human serum ah specif releas specif releas lak activ cytotox nk-resist cell line patient lymphocyt cell ifn control unchang signific differ group patient differ histolog type tumor differ stage diseas NK activ kill nk-sensit target cell patient lymphocyt differ control lymphocyt specif releas specif releas studi feasibl ifn therapi patient bronchogen carcinoma 